Bone Biologics Corp (BBLG)
About Bone Biologics Corp
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2020
- $1.1B
- Net income
- -$3.1M
- Total assets
- $5.8M
- Market cap
- $2.2M
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $3.2M
- Operating income
- -$3.2M
- Net income
- -$3.1M
- EPS (basic)
- $-2.65
- EPS (diluted)
- $-2.65
Balance sheet
- Total assets
- $5.8M
- Current assets
- $5.8M
- Total liabilities
- $418.6K
- Current liabilities
- $418.6K
- Shareholders’ equity
- $5.4M
Cash flow
- Operating cash flow
- -$2.7M
- Investing cash flow
- -$2.0M
- Financing cash flow
- $4.7M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.2M
- EPS (diluted)
- $-2.65
- Shares outstanding
- 2.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 27, 2015
Bone Biologics Corp (BBLG) Stock Price
- Reported a net loss of $3.1M in FY2020.
- Trading 83% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Bone Biologics Corp.
Write a review
News about Bone Biologics Corp
News & sentiment via Polygon.io
Bone Biologics Corp: frequently asked questions
Is Bone Biologics Corp an American company?
Bone Biologics Corp is a US-based company headquartered in Burlington, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Bone Biologics Corp headquartered?
Bone Biologics Corp is headquartered in Burlington, Massachusetts, United States.
Is Bone Biologics Corp publicly traded?
Yes — Bone Biologics Corp is a publicly traded company. Its stock trades under the ticker symbol BBLG on the NASDAQ.
What does Bone Biologics Corp do?
Bone Biologics Corp is an American Medical Devices company in the Health & Beauty sector.
